N. Hamilton, D. Márquez-Garbán, Ben Rogers, David Austin, K. Foos, A. Tong, Diana Adams, J. Vadgama, M. Brecht, R. Pietras
{"title":"胰岛素样生长因子- 1受体/胰岛素受体(IGF1R/IR)和雄激素受体(AR)拮抗剂的双重治疗抑制三阴性乳腺癌细胞的体外迁移","authors":"N. Hamilton, D. Márquez-Garbán, Ben Rogers, David Austin, K. Foos, A. Tong, Diana Adams, J. Vadgama, M. Brecht, R. Pietras","doi":"10.32392/biomed.69","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93816,"journal":{"name":"SPG biomed","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Dual Therapy with Insulin-Like Growth Factor-I Receptor/Insulin Receptor (IGF1R/IR) and Androgen Receptor (AR) Antagonists Inhibits Triple-Negative Breast Cancer Cell Migration In Vitro\",\"authors\":\"N. Hamilton, D. Márquez-Garbán, Ben Rogers, David Austin, K. Foos, A. Tong, Diana Adams, J. Vadgama, M. Brecht, R. Pietras\",\"doi\":\"10.32392/biomed.69\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93816,\"journal\":{\"name\":\"SPG biomed\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SPG biomed\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32392/biomed.69\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SPG biomed","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32392/biomed.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dual Therapy with Insulin-Like Growth Factor-I Receptor/Insulin Receptor (IGF1R/IR) and Androgen Receptor (AR) Antagonists Inhibits Triple-Negative Breast Cancer Cell Migration In Vitro